Eupraxia Pharmaceuticals Inc. (TSX:EPRX)
Canada
· Delayed Price · Currency is CAD 5.33
-0.07 (-1.30%)
May 12, 2025, 4:00 PM EDT
Eupraxia Pharmaceuticals Market Cap
Eupraxia Pharmaceuticals has a market cap or net worth of CAD 191.08 million as of May 13, 2025. Its market cap has increased by 43.81% in one year.
Market Cap
191.08M
Enterprise Value
195.01M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.33
Market Cap Chart
Since March 9, 2021, Eupraxia Pharmaceuticals's market cap has increased from 78.01M to 191.08M, an increase of 144.95%. That is a compound annual growth rate of 23.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 191.08M | 18.93% |
| Dec 31, 2024 | 160.66M | 9.74% |
| Dec 29, 2023 | 146.40M | 85.76% |
| Dec 30, 2022 | 78.81M | 125.87% |
| Dec 31, 2021 | 34.89M | -55.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Green Thumb Industries | 1.81B |
| dentalcorp Holdings | 1.77B |
| Sienna Senior Living | 1.62B |
| Extendicare | 1.20B |
| Trulieve Cannabis | 1.16B |
| Cronos Group | 1.09B |
| WELL Health Technologies | 1.03B |
| Curaleaf Holdings | 863.42M |